117 results
Posted on 06.06.2018
Reinventing asthma inhalers for the digital age
Asthma is a very common disease. In Europe, at least one in ten children has asthma symptoms. Globally, an estimated 300 million people are living with the condition. For people with asthma, their inhaler plays a central role in managing the condition. These simple drug delivery devices have been used for decades to deliver medication […]
Posted on 25.05.2018
IVDR/MDR transition periods: It’s time to talk about time
One year has now passed since the ‘new’ EU IVD and medical devices regulations entered into force. Since Day 1, the medical technology industry has been working at full capacity to achieve and maintain maximum possible readiness. While I’d love to claim the same for all other essential elements of the new regulatory system, progress […]
Posted on 26.03.2018
Swifter, Higher, Stronger: Promoting MedTech Ethics on the Global Stage
This blog is part of the GMTCC 2018 blog series. You can follow the conversation under #GMTCC and find more details and at gmtcc.com. Check out related blogs: How to create and maintain an ethical culture, Global Responsibility, Global Ethics and Compliance, Global Principles for MedTech Innovation, Progress and new challenges after 10 years of collaboration, Distributors play key role […]
Posted on 22.03.2018
Czech medtech: two decades of change
As CzechMed celebrates its 20th anniversary on 22 March 2018, Miroslav Palát, President of the association discusses the past, present and future Czechia was a different place in 1998 when CzechMed was established to represent the medical devices sector. Since then, the economy has grown by an average of 2.5% per year – with the […]
Posted on 11.12.2017
Spanish medtech: looking to the future (old top)
In its 40-year history, Fenin, the Spanish medtech federation, has seen enormous changes in Spain’s healthcare landscape. In the second part of a two-part interview, Margarita Alfonsel, General Secretary of Fenin, shares her thoughts on the future. Read part one, reflecting on Fenin’s 40-year history Q. How is Fenin working to shape the future of […]
Posted on 23.08.2017
Feeling lost? Find your direction with the new IVD/MD regulations training
MedTech Europe and IVDR & MDR training: a contribution There has been a lot of noise in the MedTech community on the recently adopted in vitro diagnostic medical devices regulation (IVDR) and the medical devices regulation (MDR). These new regulations were some 10 years in the making, yet many details still have to be clarified […]
Posted on 17.07.2017
Restoring vision: we can help people to see again
People with a rare eye disease known as retinitis pigmentosa (RP) suffer a gradual loss of vision; some become completely blind. Now, an innovative new approach to treatment has given dozens of people the chance to see again. With the help of a retinal implant, special glasses and intensive training, people who were blind have […]
Posted on 03.05.2017
Considerations on European transparency rules for the future
Following on the footsteps of our American colleagues, MedTech Europe would like to offer some thoughts on the issue of transparency and disclosure laws and how certain adaptations could help to frame transparency for a new reality. Over the last few years, a number of European countries have passed transparency or disclosure (sometimes also called “Sunshine”) laws […]
Posted on 29.03.2017
Looking the Other Way: What About Upstream Corporate Considerations?
As a medtech lawyer, my focus naturally gravitates to assessing “downstream” relationships and risk; that is, analysis of the legal arrangements between manufacturers, distribution agents, and health care providers that together bring medical technologies to the patient’s bedside. These relationships can be complex, as are the legal issues they raise. But ensuring ethical standards in these relationships […]